Please select the option that best describes you:
Topics:
Breast Cancer • Radiation Oncology
Would you recommend covering the dissected axilla in your radiation field in patients with cN2/N3 disease who had complete response to neoadjuvant chemo and an ALND?
What if ALND reveals no residual disease?
Answer from: Radiation Oncologist at Academic Institution
It has been my practice to cover the dissected axilla in these cases with cN2/3 disease, even with a pCR and ALND. I have not seen huge volume reductions when you plan with 3D-CRT and have tangents and an AP SCV field, so Im not sure how much you gain in terms of volume irradiated and potential toxi...
Sign in or Register to read more
Answer from: Radiation Oncologist at Community Practice
One additional measure I take is to compare the pre chemo scan to the planning scan, and any potential residual node at any level in axilla or IM which is not dissected would boost to a higher dose.
Comments
Radiation Oncologist at Naval Medical Center San Diego
I am considering boosting potential residual LNs (...
I am considering boosting potential residual LNs (...
Radiation Oncologist at Varian Medical Systems/Allegheny health network
No outcome data, but the practice pattern is based...
No outcome data, but the practice pattern is based...
Radiation Oncologist at Cleveland Clinic
Agreed, if I see residual based on planning, I do ...
Agreed, if I see residual based on planning, I do ...